AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 6th, 2020 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Executive Employment Agreement (the “Agreement”), is entered into and effective as of the 29th day of January, 2016 (the “Effective Date”), by and between Yumanity Therapeutics, Inc., a Delaware corporation (the “Company”), the successor to Yumanity Pharmaceuticals, LLC, and N. Anthony Coles, MD (“Executive”) and supersedes, in its entirety, that certain Executive Employment Agreement between Executive and the Company, dated as of October 3, 2014, as amended through the Effective Date (the “2014 Agreement”).
